Cargando…
The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis
Background: Migraine is the most common acute primary headache in children and adolescents. In 2014, topiramate became the first preventive drug for migraine, approved by the Food and Drug Administration (FDA) for adolescents. This meta-analysis was aimed to evaluate the efficacy and safety of topir...
Autores principales: | Wu, Xinwei, Zhang, Yan, Lu, Mei, Yu, Xiaolin, Ye, Xiang, Wang, Xingbang, Shan, Peiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056737/ https://www.ncbi.nlm.nih.gov/pubmed/32175291 http://dx.doi.org/10.3389/fped.2020.00028 |
Ejemplares similares
-
The efficacy and safety of antiepileptics in the prophylaxis of pediatric migraine: the meta-analysis of randomized controlled trials
por: Jia, Guoyong, et al.
Publicado: (2021) -
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
por: Naegel, Steffen, et al.
Publicado: (2010) -
Topiramate: Safety and Efficacy of its Use in the Prevention and Treatment of Migraine
por: Minton, Ginger C., et al.
Publicado: (2011) -
Topiramate in the prevention of pediatric migraine: literature review
por: Ferraro, Diana, et al.
Publicado: (2008) -
The Efficacy and Safety of Topiramate for Prophylaxis of Migraine in Children
por: FALLAH, Razieh, et al.
Publicado: (2013)